STOCK TITAN
  1. Home
  2. Sec-filings
  3. CNMD
  4. [Form 3] CONMED Corp Initial Statement of Beneficial Ownership

New CONMED (CNMD) director Jeffrey Mirviss reports no common stock holdings

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
3

Rhea-AI Filing Summary

CONMED Corp filed an initial insider ownership report for Jeffrey B. Mirviss, who became a Director on July 1, 2026. The filing lists his position in the company’s Common Stock.

The report shows he held 0 shares of Common Stock following the reported date, meaning no beneficial ownership is reported at this time.

Positive

  • None.

Negative

  • None.
Insider Mirviss Jeffrey B.
Role null
Type Security Shares Price Value
holding Common Stock -- -- --
Holdings After Transaction: Common Stock — 0 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Common Stock ownership 0 shares Total shares following transaction as of July 1, 2026
Holding entries 1 entry Initial ownership status reported on Form 3
Common Stock financial
"security_title: "Common Stock""
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
Director financial
"Jeffrey B. Mirviss became a Director of CONMED on July 1, 2026."
transaction code regulatory
"transaction_code_description: "Unknown transaction code""
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Understanding Insider Trading Forms →
SEC Form 3
FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104
Estimated average burden
hours per response:0.5
1. Name and Address of Reporting Person*
Mirviss Jeffrey B.
(Last)(First)(Middle)
C/O CONMED CORPORATION
11311 CONCEPT BOULEVARD
(Street)
LARGO FLORIDA 33773
(City)(State)(Zip)
UNITED STATES
(Country)		2. Date of Event Requiring Statement (Month/Day/Year)
07/01/2026		3. Issuer Name and Ticker or Trading Symbol
CONMED Corp [ CNMD ]
3a. Foreign Trading Symbol
5. If Amendment, Date of Original Filed (Month/Day/Year)
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock0D(1)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Jeffrey B. Mirviss became a Director of CONMED on July 1, 2026.
/s/ Thomas Fistek for Jeffrey B. Mirviss by Power of Attorney07/02/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What does Jeffrey B. Mirviss’s Form 3 filing show for CONMED Corp (CNMD)?

The Form 3 for Jeffrey B. Mirviss shows his initial insider ownership status in CONMED Corp. It indicates his role as a Director and reports his position in the company’s Common Stock as of July 1, 2026.

How many CONMED Corp (CNMD) shares does Jeffrey B. Mirviss report owning on Form 3?

Jeffrey B. Mirviss reports owning 0 shares of CONMED Corp Common Stock on his Form 3. The filing’s total_shares_following_transaction field for Common Stock is 0.0000, indicating no beneficial ownership reported at that time.

When did Jeffrey B. Mirviss become a Director of CONMED Corp (CNMD)?

Jeffrey B. Mirviss became a Director of CONMED Corp on July 1, 2026. This date is disclosed in a footnote, which explains that his appointment as a Director coincides with the timing of the initial Form 3 ownership report.

Does the CONMED Corp (CNMD) Form 3 for Jeffrey B. Mirviss show any stock transactions?

The Form 3 does not report any buy or sell transactions for Jeffrey B. Mirviss. Transaction fields show no purchases or sales, and his total_shares_following_transaction for Common Stock is 0.0000, reflecting only his initial ownership status.

What type of security is reported in Jeffrey B. Mirviss’s CONMED Corp (CNMD) Form 3?

The Form 3 lists CONMED Corp “Common Stock” as the security associated with Jeffrey B. Mirviss. For this security, the filing reports a total_shares_following_transaction of 0.0000, indicating no Common Stock ownership at the time of the report.